Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Metabolic and skeletal complications of HIV infection: the price of success.

Morse CG, Kovacs JA.

JAMA. 2006 Aug 16;296(7):844-54.

PMID:
16905789
2.
3.

Reviewing the cardiovascular complications of HIV infection after the introduction of highly active antiretroviral therapy.

Barbaro G.

Curr Drug Targets Cardiovasc Haematol Disord. 2005 Aug;5(4):337-43.

PMID:
16101566
4.

Highly active antiretroviral therapy and cardiovascular complications in HIV-infected patients.

Barbaro G, Klatt EC.

Curr Pharm Des. 2003;9(18):1475-81. Review.

PMID:
12769727
5.

Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients.

Tomazic J, Silic A, Karner P, Vidmar L, Maticic M, Poljak M, Ihan A, Janez A.

Wien Klin Wochenschr. 2004 Nov 30;116(21-22):755-9.

PMID:
15628647
6.

Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Grinspoon S, Carr A.

N Engl J Med. 2005 Jan 6;352(1):48-62. Review. No abstract available.

7.

Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease.

Anuurad E, Semrad A, Berglund L.

Metab Syndr Relat Disord. 2009 Oct;7(5):401-10. doi: 10.1089/met.2008.0096. Review.

8.

Highly active antiretroviral therapy-associated metabolic syndrome and cardiovascular risk.

Barbaro G, Barbarini G.

Chemotherapy. 2006;52(4):161-5. Epub 2006 May 2. Review.

PMID:
16675900
9.

Management of the metabolic effects of HIV and HIV drugs.

Brown TT, Glesby MJ.

Nat Rev Endocrinol. 2011 Sep 20;8(1):11-21. doi: 10.1038/nrendo.2011.151. Review.

10.

Lipodystrophy syndrome: the morphologic and metabolic effects of antiretroviral therapy in HIV infection.

Norris A, Dreher HM.

J Assoc Nurses AIDS Care. 2004 Nov-Dec;15(6):46-64. Review.

PMID:
15538016
11.

[HIV infection: emerging issues and new challenges].

Calza L, Manfredi R, Chiodo F.

Recenti Prog Med. 2006 Dec;97(12):771-80. Review. Italian.

PMID:
17252736
12.

HIV and increased risk of cardiovascular diseases.

Das S.

Sex Health. 2005;2(4):219-21. Review.

PMID:
16402668
14.

HIV lipodystrophy and its metabolic consequences: implications for clinical practice.

Wierzbicki AS, Purdon SD, Hardman TC, Kulasegaram R, Peters BS.

Curr Med Res Opin. 2008 Mar;24(3):609-24. doi: 10.1185/030079908X272742. Review.

PMID:
18208641
15.
16.

Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy.

Calza L, Manfredi R, Pocaterra D, Chiodo F.

J Infect. 2008 Jul;57(1):16-32. doi: 10.1016/j.jinf.2008.02.006. Epub 2008 Mar 21. Review.

PMID:
18358535
17.
18.

[Lipodystrophy syndrome in HIV-infected patients. Clinical and diagnostic features].

Streinu-Cercel A, Ion DA, Chivu LI, Chivu RD.

Rev Med Chir Soc Med Nat Iasi. 2006 Jul-Sep;110(3):521-5. Review. Romanian.

PMID:
17571539
19.

Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.

Calza L, Manfredi R, Chiodo F.

J Antimicrob Chemother. 2004 Jan;53(1):10-4. Epub 2003 Nov 25. Review.

PMID:
14645323
20.

Antiretroviral therapy and the human immunodeficiency virus--improved survival but at what cost?

Bradbury RA, Samaras K.

Diabetes Obes Metab. 2008 Jun;10(6):441-50. Epub 2007 Sep 6. Review.

PMID:
17825081

Supplemental Content

Support Center